This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogra, P. L.
Right arrow Articles by Welliver, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogra, P. L.
Right arrow Articles by Welliver, R. C.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, April 2001, p. 430-445, Vol. 14, No. 2
0893-8512/01/$04.00+0   DOI: 10.1128/CMR.14.2.430-445.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Vaccination Strategies for Mucosal Immune Responses

Pearay L. Ogra,* Howard Faden, and Robert C. Welliver

Department of Pediatrics, Division of Infectious Diseases, State University of New York at Buffalo, and Children's Hospital of Buffalo, Buffalo, New York

Mucosal administration of vaccines is an important approach to the induction of appropriate immune responses to microbial and other environmental antigens in systemic sites and peripheral blood as well as in most external mucosal surfaces. The development of specific antibody- or T-cell-mediated immunologic responses and the induction of mucosally induced systemic immunologic hyporesponsiveness (oral or mucosal tolerance) depend on complex sets of immunologic events, including the nature of the antigenic stimulation of specialized lymphoid structures in the host, antigen-induced activation of different populations of regulatory T cells (Th1 versus Th2), and the expression of proinflammatory and immunoregulatory cytokines. Availability of mucosal vaccines will provide a painless approach to deliver large numbers of vaccine antigens for human immunization. Currently, an average infant will receive 20 to 25 percutaneous injections for vaccination against different childhood infections by 18 months of age. It should be possible to develop for human use effective, nonliving, recombinant, replicating, transgenic, and microbial vector- or plant-based mucosal vaccines to prevent infections. Based on the experience with many dietary antigens, it is also possible to manipulate the mucosal immune system to induce systemic tolerance against environmental, dietary, and possibly other autoantigens associated with allergic and autoimmune disorders. Mucosal immunity offers new strategies to induce protective immune responses against a variety of infectious agents. Such immunization may also provide new prophylactic or therapeutic avenues in the control of autoimmune diseases in humans.

* Corresponding author. Mailing address: Division of Infectious Diseases, Children's Hospital of Buffalo, 219 Bryant St., Buffalo, NY 14222. Phone: (716) 878-7407. Fax: (716) 888-3804. E-mail: pogra{at}upa.chob.edu.

Clinical Microbiology Reviews, April 2001, p. 430-445, Vol. 14, No. 2
0893-8512/01/$04.00+0   DOI: 10.1128/CMR.14.2.430-445.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gauthier, Y. P., Tournier, J.-N., Paucod, J.-C., Corre, J.-P., Mock, M., Goossens, P. L., Vidal, D. R. (2009). Efficacy of a Vaccine Based on Protective Antigen and Killed Spores against Experimental Inhalational Anthrax. Infect. Immun. 77: 1197-1207 [Abstract] [Full Text]  
  • Cubillos, C., de la Torre, B. G., Jakab, A., Clementi, G., Borras, E., Barcena, J., Andreu, D., Sobrino, F., Blanco, E. (2008). Enhanced Mucosal Immunoglobulin A Response and Solid Protection against Foot-and-Mouth Disease Virus Challenge Induced by a Novel Dendrimeric Peptide. J. Virol. 82: 7223-7230 [Abstract] [Full Text]  
  • Patel, G. B., Ponce, A., Zhou, H., Chen, W. (2008). Safety of Intranasally Administered Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery (AMVAD) Vaccine in Mice. International Journal of Toxicology 27: 329-339 [Abstract] [Full Text]  
  • Hajishengallis, G., Arce, S., Gockel, C.M., Connell, T.D., Russell, M.W. (2005). Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections. JDR 84: 1104-1116 [Abstract] [Full Text]  
  • Gherardi, M. M., Esteban, M. (2005). Recombinant poxviruses as mucosal vaccine vectors. J. Gen. Virol. 86: 2925-2936 [Abstract] [Full Text]  
  • Aloni-Grinstein, R., Gat, O., Altboum, Z., Velan, B., Cohen, S., Shafferman, A. (2005). Oral Spore Vaccine Based on Live Attenuated Nontoxinogenic Bacillus anthracis Expressing Recombinant Mutant Protective Antigen. Infect. Immun. 73: 4043-4053 [Abstract] [Full Text]  
  • Pogrebnyak, N., Golovkin, M., Andrianov, V., Spitsin, S., Smirnov, Y., Egolf, R., Koprowski, H. (2005). Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine. Proc. Natl. Acad. Sci. USA 102: 9062-9067 [Abstract] [Full Text]  
  • Elahi, S., Brownlie, R., Korzeniowski, J., Buchanan, R., O'Connor, B., Peppler, M. S., Halperin, S. A., Lee, S. F., Babiuk, L. A., Gerdts, V. (2005). Infection of Newborn Piglets with Bordetella pertussis: a New Model for Pertussis. Infect. Immun. 73: 3636-3645 [Abstract] [Full Text]  
  • Alignani, D., Maletto, B., Liscovsky, M., Ropolo, A., Moron, G., Pistoresi-Palencia, M. C. (2005). Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J. Leukoc. Biol. 77: 898-905 [Abstract] [Full Text]  
  • Garcia, L., Jidy, M. D., Garcia, H., Rodriguez, B. L., Fernandez, R., Ano, G., Cedre, B., Valmaseda, T., Suzarte, E., Ramirez, M., Pino, Y., Campos, J., Menendez, J., Valera, R., Gonzalez, D., Gonzalez, I., Perez, O., Serrano, T., Lastre, M., Miralles, F., del Campo, J., Maestre, J. L., Perez, J. L., Talavera, A., Perez, A., Marrero, K., Ledon, T., Fando, R. (2005). The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy Volunteers. Infect. Immun. 73: 3018-3024 [Abstract] [Full Text]  
  • Kotloff, K. L., Wasserman, S. S., Jones, K. F., Livio, S., Hruby, D. E., Franke, C. A., Fischetti, V. A. (2005). Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a Streptococcus gordonii Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine. Infect. Immun. 73: 2360-2366 [Abstract] [Full Text]  
  • Gherardi, M. M., Perez-Jimenez, E., Najera, J. L., Esteban, M. (2004). Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule. J. Immunol. 172: 6209-6220 [Abstract] [Full Text]  
  • Chen, L., Wang, J., Zganiacz, A., Xing, Z. (2004). Single Intranasal Mucosal Mycobacterium bovis BCG Vaccination Confers Improved Protection Compared to Subcutaneous Vaccination against Pulmonary Tuberculosis. Infect. Immun. 72: 238-246 [Abstract] [Full Text]  
  • Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L., Muller, M. (2003). Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants. J. Virol. 77: 9211-9220 [Abstract] [Full Text]  
  • Gherardi, M. M., Najera, J. L., Perez-Jimenez, E., Guerra, S., Garcia-Sastre, A., Esteban, M. (2003). Prime-Boost Immunization Schedules Based on Influenza Virus and Vaccinia Virus Vectors Potentiate Cellular Immune Responses against Human Immunodeficiency Virus Env Protein Systemically and in the Genitorectal Draining Lymph Nodes. J. Virol. 77: 7048-7057 [Abstract] [Full Text]  
  • Biet, F., Kremer, L., Wolowczuk, I., Delacre, M., Locht, C. (2003). Immune Response Induced by Recombinant Mycobacterium bovis BCG Producing the Cholera Toxin B Subunit. Infect. Immun. 71: 2933-2937 [Abstract] [Full Text]  
  • Jiao, X., Hirano, T., Hou, Y., Gu, X.-X. (2002). Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate Vaccine. Infect. Immun. 70: 5982-5989 [Abstract] [Full Text]  
  • Harrington, P. R., Lindesmith, L., Yount, B., Moe, C. L., Baric, R. S. (2002). Binding of Norwalk Virus-Like Particles to ABH Histo-Blood Group Antigens Is Blocked by Antisera from Infected Human Volunteers or Experimentally Vaccinated Mice. J. Virol. 76: 12335-12343 [Abstract] [Full Text]  
  • Doherty, T. M., Olsen, A. W., van Pinxteren, L., Andersen, P. (2002). Oral Vaccination with Subunit Vaccines Protects Animals against Aerosol Infection with Mycobacterium tuberculosis. Infect. Immun. 70: 3111-3121 [Abstract] [Full Text]  
  • Harrington, P. R., Yount, B., Johnston, R. E., Davis, N., Moe, C., Baric, R. S. (2002). Systemic, Mucosal, and Heterotypic Immune Induction in Mice Inoculated with Venezuelan Equine Encephalitis Replicons Expressing Norwalk Virus-Like Particles. J. Virol. 76: 730-742 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»